| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |